Clinical Trial Update: Safety and Efficacy of Empagliflozin (BI 10773) in Type 1 Diabetes Mellitus Patients With or Without Renal Hyperfiltration [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of empagliflozin in patients with Type 1 diabetes, with or without renal hyperfiltration. Results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2014-06-17